このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

教育における感情的および学力的課題を防止するための統一プロトコル (U-PEACE)

2026年11月17日 更新者:Jill May Ehrenreich、University of Miami

教育における感情的および学業上の課題を防止するための統一プロトコル (U-PEACE) ランダム化対照試験

The purpose of the study is to evaluate the feasibility and effectiveness of a program for high school students with emotional and academic challenges U-PEACE and gaining feedback on that program.

調査の概要

状態

積極的、募集していない

条件

研究の種類

介入

入学 (推定)

72

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Florida
      • Coral Gables、Florida、アメリカ、33146
        • University of Miami

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

13年~18年 (子、大人)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

Youth:

  1. Adolescents between the ages of 13 and 18 years at the time of enrollment, who:

    1. display depressive symptoms above the clinical cut-off of 9 or above on the Patient Health Questionnaire-8 (PHQ-8),
    2. display elevated anxiety symptoms of 10 or above on the Generalized Anxiety Disorder 7-item Scale (GAD-7; Spitzer et al., 2006),
    3. are enrolled at the target High Schools (HS),
    4. have expressed interest in participating in the study, and
    5. have a caregiver who is available to sign study consent forms (if under 18 years of age)
  2. Adolescents must be, or are willing to be, consented to receive services through School Health Initiative (SHI) (i.e., SHI consent). If they are under 18 years of age, their caregiver must provide consent.

  3. Adolescents and caregivers are able to complete all study procedures in English or Spanish.

Teachers:

  1. Individuals who are 18 years or older.
  2. Individuals who are currently employed at the target HSs.
  3. Individuals who are able to speak, read, and understand English.

Youth Exclusion Criteria:

  1. The following individuals may be excluded at any time (e.g., before consent, after being enrolled).

    1. Individuals who do not wish to participate in this study and/or who are not able to read and understand the consent/assent.
    2. Individuals with self- or caregiver-reported history of seizures, neurological problems, autism spectrum disorder, substance use disorder, or serious mental illness (e.g., schizophrenia), and any indicator of a significant cognitive delay that would make U-PEACE inappropriate (e.g., full-time special education placement)
    3. Individuals with current anxiety or depressive symptoms or active suicidality at levels where more intensive services (e.g., day treatment, inpatient) would be warranted (e.g., hospitalization for suicidal behavior in the last 12 months).
  2. Ineligible adolescents will be provided referrals to medical providers at the SHI, community agencies contracted with the Miami-Dade County Public Schools (M-DCPS) Office of Mental Health Services or emergency room settings, as appropriate.

  3. Unclear cases will be reviewed by the PI and Director of the SHI, Co-I Lisa Gwynn, D.O.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:U-PEACE Group

Participants in this group will receive the U-PEACE intervention (study participation to last approximately 13 weeks).

This program will involve about 13 group sessions, with each group session lasting approximately 40-50 minutes. The program session will be held about 2 times a week during the school day (e.g., lunch time) if the group meets in person, or at a pre-scheduled time every week if the group meets online via Zoom.

Participants will learn how to better understand emotional experiences and use this understanding to embrace agency in challenging situations. Participants will develop skills to better deal with emotions by increasing awareness of what is happening in different settings and choose how to respond. Skill-building exercises may include mindfulness practices, flexible thinking, behavioral activation, problem-solving, and exposure activities.

アクティブコンパレータ:Services As Usual (SAU) Group

Participants in this group will receive service as usual (study participation to last approximately 13 weeks).

Participants in this group will continue to receive standard of care within their school clinic.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in Adolescent Academic Problems Checklist (AAPC)
時間枠:At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)

Scores on each item range from 0 to 3, with higher scores indicating more academic problems.

At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
Therapeutic Alliance Scale for Children, Revised (TASC-R)
時間枠:Mid (approximately week 4)

Scores on each item range from 1 (not true) to 4 (very much true). This scale measures the perceived therapeutic alliance between child and therapist.

Mid (approximately week 4)
Client Satisfaction Questionnaire (CSQ)
時間枠:Mid (approximately week 4)

Total Scores range from 8 to 32, with higher scores indicating greater client satisfaction. The CSQ support used to evaluate satisfaction with a particular intervention, client self-efficacy and the likelihood of recommending the intervention to others.

Mid (approximately week 4)
Top Problems Assessment - Child Report as measured by Likert Scale
時間枠:Up to 13 weeks

The Top Problems assessment is used to identify self-reported target problems for treatment and track changes in problem severity over time. Identified top problem statements are rated on Likert scale from 0 (not at all a problem) to 10 (a huge problem).

Up to 13 weeks
Adherence to U-PEACE, as Measured by Homework Completion
時間枠:At all group sessions (up to 9 weeks)

Adherence to U-PEACE will be measured by the overall number of homework assignments completed.

At all group sessions (up to 9 weeks)
Adherence to U-PEACE, as Measured by Session Attendance
時間枠:At all group sessions (up to 9 weeks)

Adherence to U-PEACE will be measured by the overall number of sessions attended.

At all group sessions (up to 9 weeks)
Change in Revised Children's Anxiety and Depression Scale - Child Revised Short Version (RCADS-C-S)
時間枠:At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)

The Change in Revised Children's Anxiety and Depression Scale - Child Revised Short Version (RCADS-25) is 25-item self-reported scale measuring symptoms of anxiety and depression in youth. Items are rated on a 4-point scale from 1 (Never) to 4 (always) with total composite scores ranging from 0 to 75. A score of 70 or higher indicates high severity.

At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
Change in Generalized Anxiety Disorder 7-item Scale (GAD-7)
時間枠:At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)

GAD-7 evaluates core anxiety concerns across a 7-item self-report measure. Items are rated using a 4-point Likert scale from 0 (not at all) to 3 (nearly every day). It yields a total score and a rating of impairment

At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
Change in Patient Health Questionnaire 9-item Scale (Modified for Major Depressive Disorder in Adolescents; PHQ-9M)
時間枠:At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)

PHQ-9 evaluates core depression symptoms across 9 items. Items are rated on a 4-point Likert scale from 0 (not at all) to 3 (nearly every day)

At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)

二次結果の測定

結果測定
メジャーの説明
時間枠
School Achievement, as measured by attendance
時間枠:Up to approximately 13 weeks

Attendance is defined as number of days attending school (not absent)

Up to approximately 13 weeks
School Achievement, as measured by report card
時間枠:Up to approximately 13 weeks

School achievement will be measured by a numeric score on each participant's school report card

Up to approximately 13 weeks
Change in Child Anxiety Impact Scale-Academic Subscale (CAIS-AS)
時間枠:At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)

CAIS-AS is a youth- and caregiver-report measure that assesses the impact of anxiety on function. The Academic sub scale assesses the impact of anxiety on assignments and tests, getting to school on time, etc. Items are rated on a 4-point Likert scale from 0 (not at all) to 3 (very much), with higher scores indicating greater impact of anxiety symptoms on academics

At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
Change in Affective Reactivity Scale (ARI)
時間枠:At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)

ARI is a 7-item youth- and caregiver-report measure of irritability. Items are rated on a 3-point Likert scale from 0 (not true) to 2 (certainly true)

At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
Change in Distress Tolerance Scale (DTS)
時間枠:At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)

DTS is a 15-item youth report measure to evaluate emotional distress tolerance. Items are rated on a 5-point Likert scale from 1 (strongly agree) to 5 (strongly disagree)

At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Jill Ehrenreich-May, PhD、University of Miami

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2023年10月5日

一次修了 (推定)

2027年2月1日

研究の完了 (推定)

2027年2月1日

試験登録日

最初に提出

2023年9月20日

QC基準を満たした最初の提出物

2023年9月20日

最初の投稿 (実際)

2023年9月28日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月20日

QC基準を満たした最後の更新が送信されました

2026年11月17日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 20230796

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する